Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications hifmech study group plasminogen activator inhibitor 1 675 4g5g genotype influences risk
… Rothman here . Related Services Pharmacoepidemiology and Risk Management Staff Members Kenneth J Rothman …
… Sapna Rao Pharmacoepidemiology and Risk Management Headquarters - Research Triangle Park, North … in the Pharmacoepidemiology and Risk Management group with RTI-HS. She has 10 years of full-time and … observational studies, developing protocols, developing study reports, and disseminating data to internal and …
… Manel Pladevall-Vila Pharmacoepidemiology and Risk Management Rheumatology Diabetes & Endocrine Disorders … specializing in hypertension and other cardiovascular risk factors, such as diabetes. He has over 12 years’ …
Chase Brown Business Development and Marketing Telecommuter - USA MS, Global Health Systems and Public Policy The University of Edinburgh, Edinburgh, United Kingdom BA, Latin American Studies Brigham Young University at Provo, Provo, UT Chase Brown, MS, …
… Heather Danysh Pharmacoepidemiology and Risk Management Waltham, Massachusetts, USA PhD, Epidemiology … she investigated factors associated with pediatric cancer risk with an emphasis on environmental exposures. Dr. Danysh …
… Modeler/Research Health Economist in the Health Economics group with RTI-HS. Prior to joining RTI-HS, she completed her … covering 2 annual preventative oral health visits for low-risk adults aged 18 to 64. She has experience building Markov …
… epidemiologic studies, patient outcomes research, risk management programs, and patient registries. In the last … leadership of post-authorization safety (PASS) studies and risk evaluation and mitigation strategy (REMS) assessments. … aspects of data collection, including project management, study design and implementation, questionnaire development, …
… Data Management in the Surveys and Observational Studies group at RTI-HS. She received her Master of Public Health … system programming, comprehensive testing, monitoring study progress, and adeptly addressing and identifying …
… 6 Takeaways on the AMCP 4.1 Guidance in Action Share on: March 12, 2021 Insights from … the inclusion of clinical data affect planned or pending publications? Manufacturers should determine the appropriate … (as evidence tables) or more comprehensively (as study summaries and evidence tables). Takeaway 4: Provide …
… evaluations based on clinical trial or observational study data Cross-sectional and longitudinal observational …